Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global disposable gastric tube market was valued at USD 234 million in 2024 and is projected to reach USD 355 million by 2031, exhibiting a CAGR of 6.3% during the forecast period.
Disposable gastric tubes are single-use medical devices designed for gastric decompression, feeding, or medication administration. They are inserted through the nasal passage (nasogastric) or mouth (orogastric) and advanced into the stomach. These tubes play a critical role in postoperative care, intensive care units, and palliative care settings where enteral access is required.
The market growth is primarily driven by the rising global surgical volume, increasing prevalence of chronic diseases requiring nutritional support, and growing adoption of single-use medical devices to prevent healthcare-associated infections. According to the World Health Organization, approximately 234 million major surgical procedures are performed annually worldwide, with a significant portion requiring postoperative gastric decompression. Furthermore, the Centers for Disease Control and Prevention estimates that healthcare-associated infections affect 1 in 31 hospital patients daily, driving demand for sterile, single-use medical devices.
Technological advancements in material science have led to the development of more flexible and biocompatible tubing materials, while regulatory emphasis on patient safety continues to drive market standardization. The market faces challenges including price pressure from generic manufacturers and variability in healthcare reimbursement policies across different regions.
Geographically, North America and Europe currently hold the largest market shares due to well-established healthcare infrastructure and higher healthcare spending. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period, driven by increasing healthcare expenditure, growing medical tourism, and rising awareness about hospital-acquired infections.
Rising Prevalence of Gastrointestinal Disorders
The increasing incidence of gastrointestinal diseases, including gastric cancers, peptic ulcers, and motility disorders, is driving demand for disposable gastric tubes. Hospitals and clinics require these devices for both diagnostic and therapeutic procedures, particularly as global aging populations present higher rates of age-related digestive conditions.
Growth in Minimally Invasive Procedures
The shift toward minimally invasive surgical techniques continues to accelerate across global healthcare systems. Disposable gastric tubes are essential components in endoscopic procedures, laparoscopic surgeries, and other minimally invasive approaches that reduce recovery times and hospital stays. This trend is particularly strong in bariatric surgery and oncology departments.
The global endoscopic devices market is projected to reach $42.7 billion by 2028, driving demand for compatible disposable components including gastric tubes
Advancements in material science have enabled the development of more flexible, biocompatible, and cost-effective disposable gastric tubes. These innovations allow for better patient comfort and reduced risk of complications, while manufacturers benefit from reduced production costs through improved manufacturing techniques and economies of scale.
MARKET CHALLENGES
Regulatory Compliance and Certification Delays
Medical device manufacturers face increasing regulatory scrutiny across different regions, with varying approval processes for Class II medical devices like disposable gastric tubes. The FDA's 510(k) clearance process typically takes 90-180 days, but recent backlogs have extended this timeline, delaying product launches and market entry for smaller manufacturers with limited resources to navigate complex regulatory landscapes.
Other Challenges
Supply Chain Disruptions
The global medical device supply chain continues to experience disruptions stemming from pandemic-related factory closures, raw material shortages, and transportation bottlenecks. Specialty polymers used in gastric tube production face supply constraints, while shipping delays and increased costs impact profitability, particularly for smaller manufacturers without long-term supplier contracts.
High Cost of Advanced Materials
Premium-grade biocompatible polymers and specialized coatings significantly increase production costs for high-performance disposable gastric tubes. Medical-grade silicone, polyurethane, and other advanced materials with enhanced biocompatibility and reduced friction characteristics can account for up to 60% of total manufacturing costs. This pricing pressure is particularly challenging in price-sensitive emerging markets and affects adoption rates in cost-conscious healthcare systems.
Emerging Markets Expansion
Developing regions with expanding healthcare infrastructure present significant growth opportunities. Countries across Asia Pacific, Latin America, and Middle East are increasing healthcare spending and improving hospital infrastructure. The Indian medical devices market is expected to grow at 15.8% CAGR through 2027, while China's healthcare reforms continue to drive demand for single-use medical devices including gastric tubes with projected market growth of 12-15% annually in these regions.
Technological innovations in suction and irrigation systems are creating new application areas for disposable gastric tubes. Integrated systems with real-time pressure monitoring and automated fluid management are enabling more precise procedures in gastroenterology and intensive care. These advancements open new market segments beyond traditional applications, particularly in critical care and complex surgical procedures where precision fluid management is critical to patient outcomes.
| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Nasogastric Tubes dominate the market due to their widespread adoption in hospital settings for both feeding and medication administration, offering clinicians versatile solutions across various medical disciplines. |
| By Application |
|
Enteral Feeding represents the primary application segment, driven by the growing demand for enteral nutrition in both hospital and home care settings, supported by advancements in tube design for patient comfort and ease of use. |
| By End User |
|
Hospitals & Clinics remain the dominant end-user segment due to the high volume of surgical procedures, post-operative care, and emergency interventions requiring gastric tube utilization, supported by comprehensive hospital infrastructure and skilled medical staff. |
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
Medtronic plc (Ireland) maintains its leadership position through extensive R&D investments and broad product portfolio across enteral feeding and gastrointestinal care segments, capturing significant market share in both developed and emerging markets.
B. Braun Melsungen AG (Germany) focuses on high-quality, cost-effective solutions with strong distribution networks across Europe and Asia, while Fresenius Kabi AG (Germany) leverages its parenteral nutrition expertise to expand into complementary gastrointestinal product lines.
Cardinal Health, Inc. (USA) continues to expand through strategic acquisitions, recently acquiring smaller regional manufacturers to enhance their gastrointestinal product offerings and distribution capabilities.
ConvaTec Group Plc (UK) differentiates through specialized product development for complex clinical cases and maintains strong clinician training programs that drive brand loyalty in hospital settings.
List of Key Disposable Gastric Tube Companies ProfiledMedtronic plc (Ireland)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Cardinal Health, Inc. (USA)
ConvaTec Group Plc (UK)
Medline Industries, Inc. (USA)
Boston Scientific Corporation (USA)
Cook Medical Inc. (USA)
The global Disposable Gastric Tube Market is experiencing significant growth due to increasing adoption of single-use medical devices across healthcare facilities. Hospitals and clinics are prioritizing infection control measures, driving demand for sterile, single-use gastric tubes that eliminate cross-contamination risks. This trend is particularly strong in North America and Europe where stringent hygiene regulations are enforced.
Other TrendsMarket Expansion in Emerging Economies
Developing countries are showing increased adoption of disposable gastric tubes as healthcare infrastructure improves and disposable income rises. Countries like India, Brazil, and China are investing heavily in modern medical equipment, creating new market opportunities. Government initiatives to upgrade public health facilities further accelerate this trend, with market growth rates exceeding 15% annually in these regions.
Recent advancements in polymer technology have enabled manufacturers to produce more flexible, biocompatible, and cost-effective disposable gastric tubes. New materials reduce patient discomfort while maintaining structural integrity during use. These innovations are particularly crucial for pediatric and geriatric applications where patient comfort is paramount. Manufacturers are investing heavily in R&D to develop tubes with enhanced lubricity and reduced insertion resistance.
Environmental Considerations and Sustainable Alternatives
While environmental concerns regarding single-use plastics persist, the medical necessity of disposable devices maintains market growth. However, manufacturers are increasingly exploring biodegradable materials and recycling programs to address sustainability concerns without compromising patient safety. The industry is seeing emergence of hybrid solutions that balance clinical needs with environmental responsibility.
Regional Analysis: Disposable Gastric Tube MarketEurope
European markets maintain strong demand despite pricing pressures from national healthcare systems. The northern European countries show nearly universal adoption in hospital settings, while Southern and Eastern European markets are experiencing rapid growth as EU funding improves medical infrastructure. Germany and the UK represent the largest markets by volume, with France and Italy showing strong growth in recent years. Environmental concerns about single-use plastics have prompted development of biodegradable options, though cost remains a barrier. The market remains mature but stable with consistent annual growth driven by replacement demand and infection control protocols.
Asia-Pacific
The Asia-Pacific region represents both the largest potential market and the fastest growing production region. China's manufacturing capabilities supply global markets while domestic demand grows at over 15% annually. India's hospital infrastructure development drives demand, particularly in private healthcare. Japan and South Korea maintain high adoption rates due to advanced medical systems and aging populations. Southeast Asian countries show rapid growth from a smaller base, particularly in urban centers. Australia and New Zealand maintain high per-capita usage with strong regulatory oversight. The region shows the most dynamic growth patterns with both established and emerging markets coexisting.
Latin America
Market growth in Latin America has been concentrated in the largest economies - Brazil, Mexico, and Argentina. These countries account for over 80% of regional demand, with other markets showing more sporadic adoption. Economic challenges have limited public healthcare system adoption, though private hospitals and specialty clinics maintain consistent usage. The market shows potential for accelerated growth as economies stabilize and healthcare investment increases. Regional manufacturing remains limited, with most products imported from North America, Europe, or increasingly from Asian manufacturers.
Middle East & Africa
Market development shows significant disparity between regions. Gulf Cooperation Council countries show adoption rates comparable to Southern Europe, while most African countries show limited usage outside major urban centers. South Africa represents nearly half of the African market, with North African countries showing gradual but steady growth. The market remains heavily dependent on imports, though local distributors have strengthened their position. Recent healthcare investments in Gulf states have created new growth opportunities, though the market remains smaller than other regions.
This market research report offers a holistic overview of the global and regional markets for the forecast period 20252032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical and biotech companies
Medical device and diagnostics manufacturers
Healthcare providers and hospital systems
Contract research and manufacturing organizations
Investors, consultants, and policy makers
-> The global disposable gastric tube market was valued at USD 234 million in 2024 and is projected to reach USD 355 million by 2031.
-> Key players include Pacific Hospital, CareU Medical, Well Lead Medical, BD, Chengdu Xinjin Shifeng Medical Apparatus&Instrument, Chongqing Huiquan Technology, Henan Scorsese Technology Development, Suzhou Songkang Medical Materials, Henan Ruike Medical Equipment, Chongqing Dalide Medical Equipment, Henan Province Jianqi Medical Equipment, Henan Gore Medical Instrument, Xinxiang Huaxi Sanitary Materials, Yangzhou Shiji Shunda Technology, Huizhong International Medical Device (Beijing), Guangdong Kangerle Medical Instruments, Shanghai Xiangsheng Medical Appliance Factory, Yangzhou Jikang Medical Treatment Apparatus, Yangzhou Yaou Technology Development, Shengguang Medical Instrument among others.
-> Key growth drivers include aging population requiring enteral nutrition, increasing surgical procedures, rising healthcare expenditure, growing prevalence of chronic diseases requiring nutritional support, and increased focus on infection control using single-use devices.
-> North America currently holds the largest market share, while Asia-Pacific is expected to witness the highest growth rate during the forecast period.
-> Emerging trends include development of antimicrobial-coated tubes, integration with digital health monitoring systems, increased use in homecare settings, and growing adoption in emerging markets with developing healthcare infrastructure.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates